Ticker Details
Xilio Therapeutics, Inc. Common Stock
IPO Date:	October 18, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$49.5M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 4.81%
Avg Daily Range (30 D):	$0.16 | 2.86%
Avg Daily Range (90 D):	$0.07 | 2.46%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.18M
Avg Daily Volume (90 D):	.33M

Trade Size
Avg Trade Size (Sh.):	297
Avg Trade Size (Sh.) (30 D):	244
Avg Trade Size (Sh.) (90 D):	390

Institutional Trades
Total Institutional Trades:	18
Avg Institutional Trade:	$2.05M
Avg Institutional Trade (30 D):	$.53M
Avg Institutional Trade (90 D):	$.53M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.69M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	42.67K

News

Apr 3, 2026 @ 8:30 PM Xilio Therapeutics Announces Inducement Grants Und... Source: Na

Feb 12, 2026 @ 2:34 AM Xilio Therapeutics Announces Pricing of Underwritt... Source: Not Specified

Oct 3, 2025 @ 1:00 PM Xilio Therapeutics Announces Upcoming Presentation... Source: Xilio Therapeutics

Jun 5, 2025 @ 10:38 PM Xilio Therapeutics Announces Closing of $50.0 Mill... Source: N/A

Jun 2, 2025 @ 10:11 AM Xilio Therapeutics Announces Proposed Public Offer... Source: Globe Newswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-4.19	$-3.76	$-4.19
Diluted EPS	$-4.19	$-3.76	$-4.19
Revenue	$43.77M	$13.69M	$43.77M
Gross Profit
Net Income / Loss	$-35.04M	$10.36M	$-35.04M
Operating Income / Loss	$-41.98M	$-11.84M	$-41.98M
Cost of Revenue
Net Cash Flow	$82.27M	$33.77M	$82.27M
PE Ratio

Splits
Mar 16, 2026	1:14